Literature DB >> 20015812

Comparison between topical honey and mafenide acetate in treatment of auricular burn.

Basir Hashemi1, Akbar Bayat, Tayebe Kazemei, Negar Azarpira.   

Abstract

The auricle is a frequently injured part of the head and neck during thermal injury leading to ear deformity. The burned ear represents one of the most difficult problems for reconstructive surgeons. Mafenide acetate is a topical agent used routinely for these patients, but it has some disadvantages including painful application and allergic rash. Some authors have reported the healing effect and antibacterial activity of honey. The study reported here was undertaken to compare the effect of honey and mafenide acetate on auricular burn in rabbit. In our study, although the pathologic score of the honey group was better than that of the mafenide group both on 14 and 21 days after burning, it was not statistically significant. In the mafenide acetate group, deep complication of burn (chondritis) was significantly lower than that of the honey group. In conclusion, in contrast to healing and antibiotic activity reported for honey, it may have failure in preventing deep bacterial complications of wound (like chondritis). So in deep wounds, the use of honey as dressing is not recommended.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015812     DOI: 10.1016/j.amjoto.2009.07.005

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  2 in total

1.  Safety of transtympanic application of 4 % manuka honey in a chinchilla animal model.

Authors:  M Aron; O V Akinpelu; K Gasbarrino; S J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-14       Impact factor: 2.503

2.  Evaluation of the effects of honey on acute-phase deep burn wounds.

Authors:  Yukari Nakajima; Kanae Mukai; Emi Komatsu; Terumi Iuchi; Yukie Kitayama; Junko Sugama; Toshio Nakatani
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-17       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.